5-Fluorouracil and Gemcitabine Potentiate the Efficacy of Oncolytic Herpes Viral Gene Therapy in the Treatment of Pancreatic Cancer

This publication has 29 references indexed in Scilit:

• Adjuvant therapy following resection for pancreatic adenocarcinoma
  Surgical Oncology Clinics of North America, 2004
• The Virginia Mason approach to localized pancreatic cancer
  Surgical Oncology Clinics of North America, 2004
• Up‐regulation of GADD34 mediates the synergistic anticancer activity of mitomycin C and a γ₁34.5 deleted oncolytic herpes virus (G207)
  The FASEB Journal, 2004
• Preclinical Safety Evaluation of G207, a Replication-Competent Herpes Simplex Virus Type 1, Inoculated Intraprostatically in Mice and Nonhuman Primates
  Human Gene Therapy, 2001
• Neoadjuvant Chemoradiotherapy for Adenocarcinoma of the Pancreas: Treatment Variables and Survival Duration
  Annals of Surgical Oncology, 2001
• Viral Shedding and Biodistribution of G207, a MuItimutated, Conditionally Replicating Herpes Simplex Virus Type 1, after Intracerebral Inoculation in Aotus
  Molecular Therapy, 2000
• Combined Therapy with Chemotherapeutic Agents and Herpes Simplex Virus Type 1 ICP34.5 Mutant (HSV-1716) in Human Non-Small Cell Lung Cancer
  Human Gene Therapy, 1999
• Enhancement of replication of genetically engineered herpes simplex viruses by ionizing radiation: a new paradigm for destruction of therapeutically intractable tumors
  Gene Therapy, 1998
• Long-Term Survival After Resection for Ductal Adenocarcinoma of the Pancreas Is It Really Improving?
  Annals of Surgery, 1995
• Computerized Quantitation of Synergism and Antagonism of Taxol, Topotecan, and Cisplatin Against Human Teratocarcinoma Cell Growth: a Rational Approach to Clinical Protocol Design
  JNCI Journal of the National Cancer Institute, 1994